The relevance of subgroup-specific treatment effects: The Studies Of Left Ventricular Dysfunction (SOLVD) revisited
Authors:
- Andrea B. ParkerAPAndrea B. Parker
- Salim YusufSYSalim Yusuf
- C.DAvid NaylorCNC.DAvid Naylor
- 1 December 2002
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 144 (6) , 941-947
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Subgroups, treatment effects, and baseline risks: Some lessons from major cardiovascular trialsAmerican Heart Journal, 2000
- The independent effects of left ventricular ejection fraction on short‐term outcomes and resource utilization following hospitalization for heart failureClinical Cardiology, 1999
- Statistics in Epidemiology: The Case-Control StudyJournal of the American Statistical Association, 1996
- An evidence based approach to individualising treatmentBMJ, 1995
- Can overall results of clinical trials be applied to all patients?The Lancet, 1995
- Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection FractionsNew England Journal of Medicine, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Large trials with simple protocols: Indications and contraindicationsControlled Clinical Trials, 1989
- Influence on prognosis and morbidity of left ventricular ejection fraction with and without signs of left ventricular failure after acute myocardial infarctionThe American Journal of Cardiology, 1988
- STRATIFICATION BY A MULTIVARIATE CONFOUNDER SCOREAmerican Journal of Epidemiology, 1976